In 1992 Peter Ratcliffe received this rejection letter from Nature. His findings were not "a sufficient advance in our understanding". 27 years later he won the Nobel Prize for the same discovery. Don't lose faith in the things you believe in.

Trump has signaled he plans to invoke the Insurrection Act in his battle with Democratic cities. The Founders ensured that we have a powerful tool to counter such tyranny, writes Stuart Stevens. lincolnsquare.media/p/state-militi…

💯 Outside the U.S., people with U.S.-based portfolios now need to budget for an additional 20% year-over-year growth to counter the USD decline.

The crash of 1929 remains the most significant—and largely misunderstood—financial disaster in modern history. And few people today “perceive the remarkable parallels between that era and today’s political and economic climate,” Andrew Ross Sorkin writes. theatlantic.com/ideas/archive/…

$XBI A Visual History of Approved ADCs, courtesy @nature cancer:

$DCTH taking '25 guidance down again from $94-98M (May), $93-96 (August) to $83-85M (today) 😱

A reminder of how $QURE AMT130 news impacts individuals and families with this blog post. We are not just dealing with numbers in a spreadsheet. curehd.blogspot.com/2025/10/as-hop… A balanced and critical analysis of the AMT130 trial news. factor-h.org/amt-130-marks-…

Nose Rub Snaking Adu Subramanian Anthony No, the FDA explicitly agreed to a specific dataset (ENROLL-HD) and a specific form of analysis on that dataset (propensity MATCHED instead of propensity weighted). They were very clear about exactly what they wanted $QURE to do and $QURE did it. Very intentional, all cleared

Despite trial win, Roche's new eye drug can't escape Eylea's shadow biopharmadive.com/news/despite-t… via BioPharma Dive

12 Things Everyone Should Know About the Dark Triad stevestewartwilliams.com/p/12-things-ev…

Morning ☕️ Either your doubts Or your dreams Will prevail Over to you 🫵 #DREAM #mornings